CRIS Current Research Information System

PISCAGLIA, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.798
EU - Europa 11.464
AS - Asia 5.110
AF - Africa 785
SA - Sud America 47
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 9
Totale 34.236
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.769
GB - Regno Unito 3.169
IT - Italia 1.980
SE - Svezia 1.587
DE - Germania 1.519
VN - Vietnam 1.518
CN - Cina 1.348
SG - Singapore 1.228
IN - India 703
IE - Irlanda 597
UA - Ucraina 587
RU - Federazione Russa 461
FR - Francia 446
TG - Togo 305
ZA - Sudafrica 261
CH - Svizzera 250
EE - Estonia 236
BG - Bulgaria 168
JO - Giordania 122
FI - Finlandia 102
CI - Costa d'Avorio 88
HR - Croazia 81
NG - Nigeria 73
BE - Belgio 70
NL - Olanda 45
SC - Seychelles 40
ES - Italia 38
IR - Iran 35
GR - Grecia 32
CA - Canada 28
JP - Giappone 23
BR - Brasile 19
TW - Taiwan 19
AT - Austria 18
AU - Australia 18
PL - Polonia 16
CZ - Repubblica Ceca 15
LB - Libano 15
CL - Cile 13
HK - Hong Kong 12
TR - Turchia 12
UZ - Uzbekistan 12
MY - Malesia 10
RO - Romania 9
EU - Europa 8
PK - Pakistan 8
DK - Danimarca 7
PH - Filippine 7
EC - Ecuador 6
KR - Corea 6
NO - Norvegia 6
DZ - Algeria 5
NZ - Nuova Zelanda 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
BA - Bosnia-Erzegovina 4
MM - Myanmar 4
PE - Perù 4
PT - Portogallo 4
AR - Argentina 3
BD - Bangladesh 3
IL - Israele 3
MK - Macedonia 3
RS - Serbia 3
BO - Bolivia 2
BY - Bielorussia 2
EG - Egitto 2
ET - Etiopia 2
HU - Ungheria 2
IQ - Iraq 2
KE - Kenya 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
MD - Moldavia 2
MU - Mauritius 2
PS - Palestinian Territory 2
RW - Ruanda 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
ID - Indonesia 1
KG - Kirghizistan 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
PA - Panama 1
SM - San Marino 1
Totale 34.236
Salva come PNG Salva come JPEG
Città #
Southend 2.896
Fairfield 2.470
Chandler 1.695
Ashburn 1.295
Dong Ket 1.102
Singapore 1.068
Woodbridge 1.060
Seattle 985
Houston 969
Wilmington 950
Cambridge 787
Princeton 756
Ann Arbor 618
Dublin 597
Bologna 389
Jacksonville 364
Lomé 305
Westminster 298
Nanjing 278
Padova 249
Berlin 232
Santa Clara 231
Bern 219
Sofia 166
Saint Petersburg 158
New York 150
Jinan 139
San Diego 130
Turin 126
Shenyang 125
Amman 122
Milan 121
Beijing 97
Nanchang 97
Medford 94
Boardman 91
Hebei 91
Abidjan 88
Dearborn 86
Helsinki 84
Changsha 80
Abeokuta 73
Mülheim 71
Brussels 69
Florence 66
Redmond 63
Rome 62
Des Moines 60
Tianjin 59
Bremen 55
Olalla 55
Falls Church 47
Jiaxing 46
Bühl 44
Norwalk 40
Mahé 38
London 37
Los Angeles 36
Redwood City 34
Guangzhou 33
Mountain View 33
Ningbo 32
Zhengzhou 32
Amsterdam 31
Lanzhou 24
Paris 24
Washington 24
Hangzhou 23
Verona 22
Frankfurt am Main 21
Taiyuan 21
Tokyo 21
Chicago 19
Haikou 19
Phoenix 19
Pune 19
Taizhou 19
Kuban 18
Lappeenranta 18
Hyderabad 17
Kunming 17
San Venanzo 17
Fuzhou 15
Hefei 15
Taipei 15
Toronto 15
West Palm Beach 15
Zanjan 15
Palermo 14
Vienna 14
Buffalo 13
Las Vegas 13
Napoli 13
San Francisco 13
Ardabil 12
Forlì 12
Frankfurt Am Main 12
Leawood 12
Moscow 12
Madrid 10
Totale 23.576
Salva come PNG Salva come JPEG
Nome #
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 206
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 204
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 197
Ablation for hepatocellular carcinoma: beyond the standard indications 192
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. 188
Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis. 185
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 183
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. 179
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 178
Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma 169
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 166
Ablazione percutanea ecoguidata mediante radiofrequenza di piccoli noduli di HCC: fattori correlati all'esito clinico e alla recidiva di malattia 165
null 164
An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinoma. 156
Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma 156
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. 154
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 153
Validation of noninvasive methods for the assessment of liver fibrosis in patients with recurrent hepatitis C after transplantation. 152
A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma 152
Imaging-based diagnosis of benign lesions and pseudolesions in the cirrhotic liver 152
Nozioni di ecografia Doppler e color-Doppler 149
Use of perfusional angiosonography in liver transplantation and conservative management of post-transplant intra-hepatic pseudo-aneurysm. 148
Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. 144
Choledochoscope-assisted percutaneous fibrin glue sealing of bile leak complicating transarterial chemoembolization of hepatocellular carcinoma after liver transplantation. 144
A benign tumour of the liver mimicking malignant liver disease--cholangiocellular adenoma. 143
Acoustic Radiation Force Impulse elastography for fibrosis evaluation in patients with chronic hepatitis C: an international multicenter study. 143
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. 142
Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? 142
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 141
Focal nodular hyperplasia: New findings at Doppler ultrasonography 141
Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. 139
AISF position paper on nonalcoholic fatty liver disease (NAFLD): updates and future directions. 139
Assessment of liver fibrosis in trnsplant recipients with recurrent HCV infection: Usefulness of transient elastography. 139
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 138
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 138
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 137
Characterization of focal liver lesions with contrast-enhanced ultrasound. 135
Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted? 135
Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular Carcinoma 134
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 134
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 134
Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. 132
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 131
Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma. 131
Bidimensional shear wave ultrasound elastography with supersonic imaging to predict presence of oesophageal varices in cirrhosis 130
Field practice studies on sorafenib: lessons in systemic treatment of hepatocellular carcinoma. 129
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging 129
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA 129
Monofocal hepatocellular carcinoma: How much does size matter? 129
Quantification of enhancement of focal liver lesions during contrast-enhanced ultrasound (CEUS). Analysis of ten selected frames is more simple but as reliable as the analysis of the entire loop for most parameters. 128
Contrast-enhanced ultrasonography to diagnose complicated acute cholecystitis 128
Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver. 127
The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in Non-Hepatic Applications: Update 2017 (Long Version) 127
Surveillance for Hepatocellular Carcinoma Also Improves Survival of Incidentally Detected Intrahepatic Cholangiocarcinoma Arisen in Liver Cirrhosis 127
Assessment of long-term prognosis at detection of early hepatocellular carcinoma remains unsolved 126
A relative deficiency of lysosomal acid lypase activity characterizes non-alcoholic fatty liver disease 125
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 125
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 124
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. 124
Extracorporeal Detoxification for Hepatic Failure Using Molecular Adsorbent Recirculating System: Depurative Efficiency and Clinical Results in a Long-Term Follow-Up 124
Clinical Impact and behaviour of serum autoantibodies in adult liver transplantation 124
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma 124
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 124
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation 124
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 123
American College of Radiology Contrast Enhanced Ultrasound Liver Imaging Reporting and Data System (CEUS LI-RADS) for the diagnosis of Hepatocellular Carcinoma: A pictorial essay 122
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 122
Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer 121
Metabolic disorders across hepatocellular carcinoma in Italy 121
The changing scenario of hepatocellular carcinoma in Italy: an update 121
Caution in the use of boldo in herbal laxatives: a case of hepatotoxicity. 119
Clinical application of artificial liver support with the Molecular Adsorbent Recirculating System (MARS): impact on cytokines and growth factors 118
An EFSUMB introduction into Dynamic Contrast-Enhanced Ultrasound (DCE-US) for quantification of tumour perfusion 117
Widen NomoGram for multinomial logistic regression: an application to staging liver fibrosis in chronic hepatitis C patients. 117
Point shear wave ultrasound elastography with Esaote compared to real-time 2D shear wave elastography with supersonic imagine for the quantification of liver stiffness 117
CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI 117
null 117
Impiego clinico del “Fegato Artificiale” MARS: effetti sulle citochine e sui fattori di crescita 116
Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study 116
Role of Real-Time Contrast-Enhanced Ultrasound in the Assessment of Metastatic Portal Vein Thrombosis. 116
Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib 115
Characterization of Small Nodules (1-3 cm) in Cirrhosis. The role of Perfusional Angiosonography, Spiral Computed Tomography and Double Contrast Magnetic Resonance 114
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 114
L'albumina 60 anni dopo: evidenze e prospettive. Dalla fisiologia alla clinica. 113
Imaging Diagnosis of Hepatocellular Carcinoma: Recent Advances of Contrast-Enhanced Ultrasonography with SonoVue 113
The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series. 112
Development and validation of a nomogram based on clinical factors and standard laboratory tests for prediction of clinically significant liver fibrosis in chronic hepatitis C virus infection. 111
Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients 111
Molecular Adsorbent Recirculating System (MARS) application in liver failure: Clinical and hemodepurative results in 22 patients 111
Stadiazione epatica dei carcinomi gastrointestinali di prima diagnosi mediante angioecografia perfusionale. Confronto con TC spirale ed ecografia convenzionale. 110
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. 110
Diagnostic accuracy of different patterns of contrast enhanced ultrasound in characterization of new nodules in liver cirrhosis with and without history of previous hepatocellular carcinoma. 110
Contrast Enhanced Imaging Pattern of Central Scar in Focal Nodular Hyperplasia. 110
Hepatorenal syndrome: Update on diagnosis and treatment 110
Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma 110
New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: A new diagnostic algorithm 110
Real-Time Contrast-Enhanced Ultrasound - a New Simple Tool for Detection of Peritoneal-Pleural Communications in Hepatic Hydrothorax. 109
Contrast enhanced ultrasonography for the evaluation of coil embolization of splenic artery aneurysm. 109
Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules 109
Characterization of liver lesions by real-time contrast-enhanced ultrasonology. 108
Totale 13.430
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.871
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.871
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.997 0 0 110 486 853 887 1.084 1.093 1.157 587 300 440
2020/20215.171 914 330 153 208 193 294 100 273 450 317 238 1.701
2021/20226.704 642 217 369 382 612 386 148 548 260 330 1.737 1.073
2022/20237.620 828 1.076 383 947 490 576 281 425 1.346 210 598 460
2023/20242.391 173 374 151 194 229 445 113 183 122 191 114 102
2024/20252.113 409 1.521 183 0 0 0 0 0 0 0 0 0
Totale 35.222